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Background: Psychological stress is one of the major risk factors for asthma exacerbation. Although
histamine in the brain acts as an excitatory and inhibitory neurotransmitter associated with psycho-
logical stress, the contribution of brain histamine to psychological stress-induced exacerbation of asthma
remains unclear. The objective of this study was to investigate the role of histamine receptors in the CNS
on stress induced asthma aggravation.
Methods: We monitored the numbers of inﬂammatory cells and interleukin (IL)-13 levels in bron-
choalveolar lavage ﬂuid, airway responsiveness to inhaled methacholine, mucus secretion in airway
epithelial cells, and antigen-speciﬁc IgE contents in sera in a murine model of stress-induced asthma
treated with epinastine (an H1R antagonist), thioperamide (an H3/4R antagonist), or solvent.
Results: All indicators of stress-induced asthma exacerbation were signiﬁcantly reduced in stressed mice
treated with epinastine compared with those treated with solvent, whereas treatment with thioper-
amide did not reduce the numbers of inﬂammatory cells in the stressed mice.
Conclusions: These results suggest that H1R, but not H3/4R, may be involved in stress-induced asthma
exacerbations in the central nervous system.
Copyright © 2016, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).logy, Tohoku Pharmaceutical
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Asthma is characterized by chronic airway inﬂammation in
response to various types of inherited and environmental factors,
which leads to wheezing, coughing, tightness in the chest, and
shortness of breath. Increasing evidence has indicated that asthma
is not a disease but a syndrome with heterogeneous pathobiology,
clinical course, and therapeutic response to medicines. Therefore,
asthma phenotypes based on pathological and clinical featuresvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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bations have been proposed to identify more effective asthma
therapies speciﬁc for each phenotype.1
In asthma pathophysiology, type 2 T-helper (Th2) cytokines,
such as interleukin (IL)-4, IL-5, and IL-13, play pivotal roles in
regulating the behavior of inﬂammatory cells; inducing B cell iso-
type switching to produce IgE; and promoting the accumulation,
activation, and prolonged survival of eosinophils. These events
initiate and maintain the cardinal features of asthma, such as
asthmatic airway inﬂammation, thereby accelerating airway
responsiveness and epithelial mucus secretion.2
Psychological and psychosocial stressors have been long
recognized as important universal risk factors for asthma exacer-
bations,3e9 which are accompanied by aggravation of airway
inﬂammation attributable to further skewing towards a Th2-
dominant cytokine proﬁle.10e14 The cognitive processes accompa-
nying psychological stress are deeply connected to asthma exac-
erbations. Activation of the anterior cingulate cortex and insula by
psychological stimuli exhibited a greater decrease in forced expi-
ratory volume in 1 s (FEV1), increased recruitment of eosinophils,
and diminished glucocorticoid inhibition of TNF-a production.15
The intensity of activation in the anterior insula in response to
asthma-relevant psychological stimuli is correlated with the
severity of airway inﬂammation evoked by allergen inhalation.16
Stress-induced brain activation results in the production and
release of stress neuropeptides, such as opioid peptides, substance
P, and histamine, which bind to membrane receptors in the central
nervous system (CNS).17,18 However, the molecular mechanism
linking psychological stress perceived in the CNS to exacerbations
of asthma pathophysiology in airways is not yet fully understood.
Histamine receptors (HRs) are a group of seven-transmembrane
G protein-coupled receptors classiﬁed to four major subtypes (H1R,
H2R, H3R, and H4R), which are expressed throughout the body
including in immune cells, gastric mucosal cells, and neurons.19
Histamine in the brain is produced by histaminergic neurons
comprising the tuberomammillary nucleus in the posterior hypo-
thalamus. Projections from the tuberomammillary nucleus extend
to almost all areas in the brain and are implicated in basic ho-
meostatic and higher brain functions such as arousal, cognition,
nociception, and responses to perceived stress.19e21
In the present study, we aimed to determine the role of HRs in
the CNS in psychological stress-induced asthma exacerbations us-
ing amurinemodel of stress asthma.We found that H1Rs in the CNS
were required for exacerbation of asthmatic airway responses
induced by the stress exposure. In contrast, H3/4Rs might be irrel-
evant in this process or function in the negative feedback control of
stressor signals in asthma exacerbation.Methods
Mice and ethical statement
Speciﬁc pathogen-free female C57BL/6 mice were purchased
from CLEA Japan (Osaka, Japan). All mice were kept under speciﬁc
pathogen-free conditions at the Institute for Animal Experimen-
tation, Tohoku Pharmaceutical University, Sendai, Japan. Mice were
housed under a 12 h/12 h light/dark cycle at a constant temperature
(22 ± 2 C). Sterilized food and water were available ad libitum. All
experimental procedures involving animals were approved by the
Committee of Animal Experiments at Tohoku Pharmaceutical
University (approval numbers: 13001-cn-a, 14002-cn, and 15001-
cn). We took the utmost care to alleviate any pain and suffering
on the part of the mice.Sensitization, antigen challenge, and stress exposure
A schematic of the experimental protocol is shown in Figure 1.
Six- to eight-week-old mice were sensitized and made to inhale
an aerosolized antigen as previously described.22 Brieﬂy, mice
were sensitized by intraperitoneal injections of 8 mg ovalbumin
(OVA; Grade V, SigmaeAldrich, St. Louis, MO, USA) adsorbed
with aluminum hydroxide (Wako Pure Chemical Industries,
Osaka, Japan) on days 0 and 5. On days 17 and 24, the mice were
challenged with aerosolized OVA (0.5% in saline) for 1 h. Psy-
chological stressors were applied on the following schedule to
avoid habituation to psychological stress: 6 h restraint per day
from day 17 to day 19, and 3 min forced swim per day from day
20 to day 23. For restraint stress (RS), each mouse was placed in
a 50-mL conical centrifuge tube with multiple ventilation holes.
For forced swimming stress (FSS), the mice were placed in a
plastic tank (19 cm in diameter, 27 cm in height) containing
15 cm water at 32 C. Non-stressed mice were deprived of food
and water, which has been used as a non-stress condition in
other rodent experiments that investigated the effect of
stress.23,24 RS and FSS are category D procedures, as are other
types of psychological stress, such as electric foot shock stress,
sound stress, and communication box-induced stress, that have
been used to investigate the exacerbation of stress-induced
allergic airway inﬂammation by many groups including us.
Category D procedures are used in these studies because expo-
sure to stress is required to induce asthma exacerbation, and
alternative methods for reducing stress fail to exacerbate the
condition.
To test the effects of HR antagonists, 2 mL epinastine as a se-
lective H1R antagonist (Tokyo Chemical Industry, Tokyo, Japan),25
ranitidine as a selective H2R antagonist (SigmaeAldrich, St. Louis,
MO, USA),25 or thioperamide as a selective H3/4R antagonist
(Sigma-Aldrich)26,27 in calcium- and magnesium-free phosphate-
buffered saline (PBS) was intracerebroventricularly administered to
selectively block HRs in the CNS 1 h before each stress exposure at
the dose indicated. Solvent was used as a negative control. Mice
were placed in a stereotactic device under anesthesia induced by
inhalation of 2% isoﬂurane in oxygen (DS Pharma Animal Health,
Tokyo, Japan). A 25Gmicroinjection needle tip was alignedwith the
bregma and then inserted into the ventricle using the following
coordinates from bregma: 1.0 mm anterior and 1.0 mm lateral.
Intracerebroventricular injection has been used generally to
selectively administer agents to the CNS.22 In our preliminary ex-
periments, the intracerebroventricularly injected solution was not
detected outside the CNS within 1 h for volumes below 5 mL. The
doses of HR antagonists used herein were based on those used in
previous studies.28,29 At the end of the experiments, the mice were
euthanized by an overdose of pentobarbital (Somnopentyl; Kyor-
itsu Seiyaku, Tokyo, Japan).Preparation of bronchoalveolar lavage (BAL) ﬂuids
BAL samples were collected with 2  0.25 mL chilled PBS
through a cannula inserted in the trachea. Total cell numbers
recovered from BAL ﬂuid were counted with a hemocytometer.
After centrifugation of the BAL ﬂuids, supernatants were stored
at 80 C for cytokine assay. For each sample, 2  105 cells were
centrifuged onto a glass slide using a Cytospin 4 (Thermo Scientiﬁc,
Waltham, MA, USA) and stained with Diff-Quick solution (Inter-
national Reagents, Kobe, Japan). The fractions of leukocytes were
analyzed by counting a minimum of 200 cells under a light
microscope.
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Fig. 1. Schematic of the experimental protocol.
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Lung resistance at the baseline and in response to aerosolized
saline and acetyl-b-methylcholine (methacholine; SigmaeAldrich)
were measured for 3 min under each condition.22 To measure
airway sensitivity, the concentration of acetyl-b-methylcholine
needed to increase lung resistance to 200% above baseline (PC200)
was calculated by interpolating the log concentration-lung resis-
tance curve from individual mice.
Lung histology
Lungs were isolated from mice 3 days after the last OVA chal-
lenge, ﬁxed in 10% buffer formalin, dehydrated, and embedded in
parafﬁn. Sections were cut at 4-mm-thick and stained with periodic
acideSchiff (PAS). Mucin production was estimated as the propor-
tion of PAS-positive cells in the total airway epithelium of bron-
chioles in the PAS-stained section. The percentage of PAS-positive
cells was calculated in each of ﬁve random bronchioles in three
lung sections from each mouse.
Measurement of OVA-speciﬁc IgE and cytokine
Serum samples were collected 3 days after the last OVA chal-
lenge. The quantities of OVA-speciﬁc IgE in serum were measured
by enzyme-linked immunosorbent assay (ELISA). Brieﬂy, microtiter
plates (Nunc A/S, Roskilde, Denmark) were coated with 10 mg/mL
OVA in bicarbonate buffer for 1 h at 37 C and then blocked with 1%
bovine serum albumin (BSA) in PBS at 4 C overnight. Prior to
testing, serum samples were diluted with 1% BSA/PBS. Horseradish
peroxidase-conjugated goat anti-mouse IgE antibodies (Bethyl
Laboratories, Montgomery, TX, USA) diluted 1:2500 were used for
detection. IgE concentrations were determined from the absor-
bance at 450 nm using that at 650 nm for reference and calculated
based on a reference standard of pooled sera from sensitized female
mice assigned as 1000 experimental units (EU)/mL. The sensitivity
was 1.9  102 EU/mL for IgE. The concentrations of IL-13 in BAL
ﬂuids were measured using an ELISA kit (eBioscience, San Diego,
CA, USA) according to the manufacturer's instructions. The limit of
detection was 1.5 pg/mL.
Statistical analysis
Statistical analysis was conducted using GraphPad Prism 5 soft-
ware (GraphPad Software, La Jolla, CA, USA). Differences between
the two groups were tested using two-tailed analysis in an unpaired
Student's t-test. Differences among four or more groups were tested
using ANOVA with post hoc analysis (Tukey's multiple comparison
test). A p-value less than 0.05 was considered signiﬁcant. Data are
expressed as the mean ± standard error of the mean (SEM).Results
Effects of HR antagonists on stress-induced exacerbations of airway
inﬂammation
The numbers of total cells, eosinophils, and lymphocytes in BAL
ﬂuid were signiﬁcantly increased by the stress exposure but
showed a dose-dependent reduction with epinastine treatment
(Fig. 2). Treatment with 3.0  109 mol epinastine signiﬁcantly
reduced the numbers of inﬂammatory cells in stressed mice to the
levels observed in non-stressed mice treated with the same dose of
epinastine and tended to reduce the numbers of total cells, eosin-
ophils, and lymphocytes in BAL ﬂuids of non-stressed mice
compared with solvent treatment, although the difference was not
statistically signiﬁcant (Fig. 2). Intracerebroventricular adminis-
tration of 3.0  109 mol ranitidine signiﬁcantly reduced the
increased numbers of total cells, eosinophils, and lymphocytes in
BAL ﬂuids of stressed mice, whereas treatment with a higher dose
(3.0  108 mol) of ranitidine did not reduce the stress-induced
increases (Supplementary Fig. 1). The effects of ranitidine in
stressed mice were not dose-dependent but reverse bell-shaped.
The maximal suppressive effect was observed at 3.0  109 mol.
In contrast, the effects of ranitidine in non-stressed mice seemed to
be dose-dependent but were not statistically signiﬁcant
(Supplementary Fig. 1). Treatment with thioperamide, an H3/4R
antagonist, did not signiﬁcantly reduce the stress-induced
increased numbers of inﬂammatory cells in BAL ﬂuid (Fig. 3),
even at a higher dosage (4.9  108 mol; data not shown).
Effects of an H1R antagonist, epinastine, on stress-induced
exacerbations of asthmatic airway responses
Lung resistance increased dose-dependently in response to
inhaled methacholine in all groups of mice. The lung resistance
to 200% above baseline (PC200) with solvent treatment tended
to be lower in stressed mice than in non-stressed mice,
although the difference was not signiﬁcant (Fig. 4). In the
stressed mice, epinastine treatment signiﬁcantly increased the
PC200 to a level similar to that in the non-stressed mice treated
with epinastine. However, in the non-stressed mice, no signif-
icant difference in PC200 was observed between solvent and
epinastine treatments.
Effects of epinastine on stress-induced exacerbations of airway
mucus secretion
The number of PAS-positive cells under solvent treatment was
signiﬁcantly higher in the stressed mice than in the non-stressed
mice (Fig. 5). In the stressed mice, treatment with epinastine
signiﬁcantly reduced the number of PAS-positive cells to the level
Fig. 2. Effects of epinastine on airway inﬂammation. Mice were sensitized and challenged with ovalbumin (OVA) in the absence (open bars) or presence (closed bars) of psy-
chological stress. Solvent or 0.3  109, 1.0  109, or 3.0  109 mol epinastine was administered intracerebroventricularly before each stress exposure. The numbers of in-
ﬂammatory cells in bronchoalveolar lavage ﬂuid were counted on day 3 after the last OVA challenge. Each group consisted of 7e17 mice from at least two independent experiments.
Data are shown as the mean ± SEM.*p < 0.05 compared with non-stressed mice treated with solvent using an unpaired Student's t-test. Differences among the data on the stressed
mice or non-stressed mice were tested using ANOVA with Tukey's multiple comparison test. #p < 0.05 compared with the stressed mice treated with solvent. NS, not signiﬁcantly
different.
Fig. 3. Effects of thioperamide on airway inﬂammation. Mice were sensitized and challenged with ovalbumin (OVA) in the absence (open bars) or presence (closed bars) of
psychological stress. Solvent or 0.01  109, 0.1  109, 0.3  109, 1.0  109, or 3.0  109 mol thioperamide was administered intracerebroventricularly before each stress
exposure. The numbers of inﬂammatory cells in bronchoalveolar lavage ﬂuid were counted on day 3 after the last OVA challenge. Each group consisted of three to four mice from
two independent experiments. Data are shown as the mean ± SEM. *p < 0.05 compared with the non-stressed mice treated with solvent using an unpaired Student's t-test.
Differences among the data on the stressed mice were tested using ANOVA with Tukey's multiple comparison test. NS, not signiﬁcantly different.
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in the non-stressed mice, no signiﬁcant difference in cell number
observed between solvent and epinastine treatments.Effects of epinastine on the stress-induced increase of IL-13 in BAL
ﬂuid
The IL-13 contents in BAL ﬂuids under solvent treatment were
signiﬁcantly higher in the stressed mice than in the non-stressed
mice (Fig. 6). In the stressed mice, treatment with epinastine
signiﬁcantly reduced the IL-13 contents to the levels measured for
non-stressed mice treated with epinastine. In the non-stressedmice, there was no signiﬁcant difference in IL-13 contents be-
tween solvent and epinastine treatments.Effects of epinastine on the stress-induced increase of OVA-speciﬁc
IgE in sera
OVA-speciﬁc IgE concentrations in sera under solvent treatment
tended to be higher in the stressed mice than in the non-stressed
mice, although the difference was not statistically signiﬁcant
(Fig. 7). In the stressed mice, treatment with epinastine signiﬁ-
cantly decreased IgE concentrations to the levels of those in the
non-stressed mice treated with epinastine. In the non-stressed
Fig. 4. Effects of epinastine on methacholine-induced airway hyperresponsiveness.
Mice were sensitized and challenged with ovalbumin (OVA) in the absence (open bars)
or presence (closed bars) of psychological stress. Solvent or 3.0  109 mol epinastine
was administered intracerebroventricularly before each stress exposure. Airway
sensitivity was measured 1 day after the last OVA challenge. Each group consisted of
six to eight mice from two independent experiments. Data are shown as the
mean ± SEM. #p < 0.05 compared with the stressed mice treated with solvent using an
unpaired Student's t-test.
Fig. 6. Effects of epinastine on interleukin (IL)-13 contents in bronchoalveolar lavage
(BAL) ﬂuid. Mice were sensitized and challenged with ovalbumin (OVA) in the absence
(open bars) or presence (closed bars) of psychological stress. Solvent or 3.0  109 mol
epinastine was administered intracerebroventricularly before each stress exposure.
BAL samples were collected on day 3 after the last OVA challenge. The concentration of
IL-13 in BAL ﬂuids was measured by enzyme-linked immunosorbent assay. Each group
consisted of 4e10 mice from two independent experiments. Data are shown as the
mean ± SEM. *p < 0.05 compared with the non-stressed mice treated with solvent;
#p < 0.05 compared with the stressed mice treated with solvent using an unpaired
Student's t-test.
Fig. 7. Effect of epinastine on ovalbumin (OVA)-speciﬁc IgE production in serum. Mice
were sensitized and challenged with OVA in the absence (open bars) or presence
(closed bars) of psychological stress. Solvent or 3.0  109 mol epinastine was
administered intracerebroventricularly before each stress exposure. Serum samples
were collected on day 3 after the last OVA challenge. The concentrations of OVA-
speciﬁc IgE in sera were measured by enzyme-linked immunosorbent assay. Each
group consisted of 8e12 mice from two independent experiments. Data are shown as
the mean ± SEM. #p < 0.05 compared with the stressed mice treated with solvent
using an unpaired Student's t-test.
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concentrations compared with solvent treatment.
Discussion
To our knowledge, this is the ﬁrst report demonstrating that HRs
in the CNS are involved in both the development and psychological
stress-induced exacerbations of allergic asthma. Histamine is a
neurotransmitter whose release is upregulated in response to
perceived stress.19 Ito et al. showed that chronic RS increased his-
tamine turnover in the nucleus accumbens and striatum in Fisher
rats.30 In addition, Gadek-Michalska et al. showed that intra-
cerebroventricular administration of an H1R agonist in rats
increased the levels of corticosterone, one of the stress hormones
released in the neuroendocrine response to psychological stress.31
The increase of serum corticosterone after stress exposure was
previously observed in thismodel of stress asthma.22 Therefore, it is
likely that histamine was released upon stress exposure in the
present study.
Epinastine seemed to increase the PC200 (Fig. 4), and reduce the
eosinophil counts (Fig. 2), the IL-13 contents in BAL ﬂuid (Fig. 6) and
the OVA-speciﬁc IgE levels in sera (Fig. 7) of non-stressed mice
compared with solvent treatment, although the differences wereFig. 5. Effects of epinastine on airway mucus secretion. Mice were sensitized and challenged with ovalbumin (OVA) in the absence (open bars) or presence (closed bars) of
psychological stress. Solvent or 3.0  109 mol epinastine was administered intracerebroventricularly before each stress exposure. Lungs were isolated from mice 3 days after the
last OVA challenge. Lung sections were prepared and stained with periodic acideSchiff (PAS). (A) Representative images of lung sections from the non-stressed and stressed mice
treated with solvent or epinastine (scale bar, 20 mm). (B) The percentage of PAS-positive cells was calculated in each of ﬁve random bronchioles in three lung sections from each
mouse. Each group consisted of 8e13 mice from two independent experiments. Data are shown as the mean ± SEM. *p < 0.05 compared with the non-stressed mice treated with
solvent; #p < 0.05 compared with the stressed mice treated with solvent using an unpaired Student's t-test.
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dependently reduce the eosinophil counts in non-stressed mice
compared with solvent treatment. Previous studies demonstrated
that H1Rs mediated the excitatory CNS functions of brain histamine
such as maintenance of wakefulness, acceleration of locomotor
activity, enhancement of learning and memory processes, and
increased pain perception, and H2Rs are thought to play similar
roles.19,32 Therefore, histamine physiologically released in the CNS
might be partially involved in the development of allergic airway
responses through the activation of H1Rs and H2Rs, which could
explain the (non-signiﬁcant) epinastine- and ranitidine-mediated
decreases in the development of allergic asthma under stress-free
conditions. However, we cannot rule out the possibility that the
procedure for intracerebroventricular administration of solvent
could induce stress via HR activation in the non-stressed mice. In
our previous study investigating the effect of a glucocorticoid re-
ceptor antagonist using the same stress model,22 subcutaneous
administration of the solvent tended to aggravate allergic airway
responses in non-stressed mice compared to untreated non-
stressed mice (unpublished data). Thus, epinastine and ranitidine
might attenuate the aggravation of asthma-related features caused
by stress from handling in non-stressed mice.
Epinastine (3.0  109 mol) and ranitidine (3.0  109 mol)
signiﬁcantly attenuated the stress-induced enhancement of asth-
matic airway responses and Th2 immune responses to the levels of
non-stressed mice treated with the antagonists (Supplementary
Fig. 1, Fig. 2,4,5,6,7). These results suggest that the stress expo-
sure exaggerated asthmatic airway responses by increasing hista-
mine release, leading to the further activation of H1Rs and H2Rs in
the CNS.
On the other hand, the intracerebroventricular administration of
an H3/4R antagonist, thioperamide, exhibited no signiﬁcant effect
on the airway inﬂammation at the same dose (Fig. 3) or at a higher
dose (4.9  108 mol; data not shown). However, within the group
receiving thioperamide administration, a bell-shaped enhance-
ment effect was observed, and the maximal effect was observed at
0.3 109 mol. H3Rs act as inhibitory auto- and hetero-receptors in
the CNS, which inhibit the synthesis and release of histamine19,33
and a number of neurotransmitters, including acetylcholine,
dopamine, noradrenaline, and serotonin, in a pathway-dependent
manner, leading to suppression of convulsion, stress-induced
excitation, and feeding behavior.20,21 The structureeactivity re-
lationships of H3R and H4R overlap as Gi/o protein-coupled re-
ceptors.34 Therefore, the activation H3Rs and H4Rs by the stress
exposure might play a suppressive role in stress-induced asthma
exacerbations.
Taken together, our ﬁndings and the physiological properties of
each HR subtype suggest that the interaction of histamine with HR
subtypes playing distinctive roles in the CNS is associated with the
severity of allergic airway responses, particularly in the case of
psychological stress-induced exacerbations. Further studies will be
required to identify the exact roles of each HR subtype in the CNS
and to elucidate how the stressor signal via HRs in the CNS mod-
ulates Th2 immune responses in asthmatic pathophysiology. The
present study presents a new insight into the global role of the
histamine-regulated CNS in allergic asthma, which might lead to
the development of more effective strategies for the management
of asthmatic patients with the stress-related asthma phenotype.
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